Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
Tiffany Thomas, … , Steven L. Spitalnik, Angelo D’Alessandro
Tiffany Thomas, … , Steven L. Spitalnik, Angelo D’Alessandro
Published June 19, 2020
Citation Information: JCI Insight. 2020;5(14):e140327. https://doi.org/10.1172/jci.insight.140327.
View: Text | PDF
Clinical Research and Public Health COVID-19 Metabolism

COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status

  • Text
  • PDF
Abstract

BACKGROUND Reprogramming of host metabolism supports viral pathogenesis by fueling viral proliferation, by providing, for example, free amino acids and fatty acids as building blocks.METHODS To investigate metabolic effects of SARS-CoV-2 infection, we evaluated serum metabolites of patients with COVID-19 (n = 33; diagnosed by nucleic acid testing), as compared with COVID-19–negative controls (n = 16).RESULTS Targeted and untargeted metabolomics analyses identified altered tryptophan metabolism into the kynurenine pathway, which regulates inflammation and immunity. Indeed, these changes in tryptophan metabolism correlated with interleukin-6 (IL-6) levels. Widespread dysregulation of nitrogen metabolism was also seen in infected patients, with altered levels of most amino acids, along with increased markers of oxidant stress (e.g., methionine sulfoxide, cystine), proteolysis, and renal dysfunction (e.g., creatine, creatinine, polyamines). Increased circulating levels of glucose and free fatty acids were also observed, consistent with altered carbon homeostasis. Interestingly, metabolite levels in these pathways correlated with clinical laboratory markers of inflammation (i.e., IL-6 and C-reactive protein) and renal function (i.e., blood urea nitrogen).CONCLUSION In conclusion, this initial observational study identified amino acid and fatty acid metabolism as correlates of COVID-19, providing mechanistic insights, potential markers of clinical severity, and potential therapeutic targets.FUNDING Boettcher Foundation Webb-Waring Biomedical Research Award; National Institute of General and Medical Sciences, NIH; and National Heart, Lung, and Blood Institute, NIH.

Authors

Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, Travis Nemkov, Lorenzo Bertolone, Richard O. Francis, Krystalyn E. Hudson, James C. Zimring, Kirk C. Hansen, Eldad A. Hod, Steven L. Spitalnik, Angelo D’Alessandro

×

Figure 2

Untargeted metabolomics analyses.

Options: View larger image (or click on image) Download as PowerPoint
Untargeted metabolomics analyses.
Untargeted metabolomics analyses were ...
Untargeted metabolomics analyses were performed using sera obtained from COVID-19–positive and –negative subjects. (A) Volcano plots highlight 3034 and 2484 differential metabolites (unique molecular formulas were determined by high-resolution, accurate intact mass, isotopic patterns, and MS/MS analyses) for negative and positive ion modes (left and right), respectively. (B) PLS-DA based on the untargeted metabolomics data further separates COVID-19–negative and –positive subjects, the latter separating from the former across principal component 1 (18.7% of the total variance) as a function of IL-6 levels. (C) Volcano plots highlight differences between COVID-19–positive subjects with low, medium, and high serum IL-6 levels, as compared with controls. (D) Pathway analysis of untargeted metabolomics data identified significant effects of COVID-19 on amino acids, especially regarding tryptophan, aspartate, arginine, tyrosine, and lysine metabolism. (E) Tryptophan metabolism, one of the top hits from pathway analysis, is mapped against KEGG pathway map hsa01100.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts